Latest News and Press Releases
Want to stay updated on the latest news?
-
SNPS STOCK NOTICE: Synopsys, Inc. Faces Securities Fraud Class Action after 36% Stock Drop – Investors with Losses Urged to Contact BFA Law
-
PHILADELPHIA, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
Synopsys, Inc. IP Underperformance Triggers Securities Class Action – Contact BFA Law before December 30 Deadline
-
Important Synopsys, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 30
-
PHILADELPHIA, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
Synopsys, Inc. Stock Dropped 36% on IP Underperformance; Contact BFA Law about the Pending Securities Class Action
-
PHILADELPHIA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
Synopsys, Inc. Hit with Securities Fraud Class Action after IP Underperformance – Contact BFA Law if You Suffered Losses
-
PHILADELPHIA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
Lose Money on Synopsys, Inc.? Contact BFA Law before December 30 Securities Class Action Deadline